Document is current

Article History

Received: 21 March 2024

Accepted: 16 August 2024

First Online: 2 October 2024

Declarations:

:

: Dr. Rotenstein receives funding from FeelBetter Inc., the American Medical Association, and AHRQ. She received prior consulting fees from Phreesia. She is on the Augmedix AI Advisory Board. Dr. LaVine is the Chair of the Clinical Practice Committee for the Society of General Internal Medicine. Dr. Sarkar holds current research funding from the National Cancer Institute, California Healthcare Foundation, the Patient-Centered Outcomes Research Institute, and the National Institutes of Health. She has received prior grant funding from the Gordon and Betty Moore Foundation, the Blue Shield of California Foundation, the Agency for Healthcare Research and Quality, HopeLab, the US Food and Drug Administration, and the Commonwealth Fund. She received gift funding from The Doctors Company Foundation. She holds contract funding from InquisitHealth and RecoverX. Dr. Sarkar serves as a scientific/expert advisor for nonprofit organizations HealthTech 4 Medicaid (volunteer) and for HopeLab (volunteer). She is a member of the American Medical Association’s Equity and Innovation Advisory Group (honoraria) and is on the Board of Directors of the Collaborative for Accountability and Improvement (volunteer). She is an advisor for Waymark (shares) and for Ceteri Capital I GP, LLC (shares). She has been a clinical advisor for Omada Health (honoraria), and an advisory board member for Doximity (honoraria). The remaining authors have nothing to disclose.